About this trial
The Study will be conducted at SKMCH \& RC Lahore. All adult patients aged 18-70 years scheduled to undergo elective laparoscopic abdominal surgery will be screened for eligibility according to inclusion \& exclusion criteria. Total number of patients is 42. Patients who meet eligibility criteria will be randomized into 2 groups, Orientation group \& Control group. In orientation group, orientation reminder will be given in the form of prerecorded voice notes via headphones to the patients. The evaluation of emergence agitation will be done by using Riker Sedation Agitation Scale. The primary outcome will be incidence of emergence agitation in the OR. Secondary outcome includes the time from sevoflurane discontinuation to eye opening, extubation, discharge to PACU as well as pain score and length of stay in the PACU.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18 to 70 years
Scheduled to undergo elective laparoscopic abdominal surgery will be screened for eligibility.
Disqualifiers
Include TIVA and inhalational agent other than sevoflurane, American Society of Anesthesiologists (ASA) physical status 4,
BMI >35 kg/m²,
Pre-existing conditions associated with neurological deficit,
Cognitive impairment if documented by neurologist
Trial design
Parallel
Treatments tested in this trial
Orientation reminder
Other interventionOrientation reminder will be given in the language which can understand by patient.
Treatment groups
Trial outcomes
Primary outcomes
incidence of emergence agitation in OR
Emergence agitation will be evaluated according to Riker Sedation Agitation Scale. Maximum SAS score will be considered for primary outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.